SCHEMBL14033868

SCHEMBL14033868

CCCC[C@H]1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CCN1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.49
CYP19A1 P11511 1/20 0.49
SLC6A2 P23975 4/20 0.43
SLC6A4 P31645 4/20 0.43
SLC6A3 Q01959 4/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
SLC6A9 P48067 2/20 0.43
DPP4 P27487 1/20 0.43
CHRM2 P08172 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
BCL2 P10415 1/20 0.39
CHRM1 P11229 1/20 0.39
DRD1 P21728 1/20 0.39
TBXA2R P21731 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39
KCNH2 Q12809 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033906 0.87 HRH3 (0.43) CYP2D6CYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL16226979 0.87 HRH3 (0.43) CYP2D6CYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL14033908 0.87 CYP2D6 (0.54) CYP2D6CYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL14034041 0.84 CYP2D6 (0.48) CYP2D6CYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL26955676 0.78 CYP2D6 (0.60) CYP2D6CYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL6582183 0.76 CYP2D6 (0.43) CYP2D6CYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL4431100 0.76 SLC6A9 (0.45) CYP2D6SLC6A2SLC6A4SLC6A3OPRD1
Hydrochloric Acid SCHEMBL8693220 0.75 MEN1 (0.45) CYP2D6OPRM1OPRD1SLC6A9DPP4
SCHEMBL6631216 0.75 HRH1 (0.58) CYP2D6CYP19A1SLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL6951585 0.75 HRH1 (0.45) CYP2D6SLC6A2SLC6A4SLC6A3OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed